Market Overview
The global medical refrigerated market was valued at USD 952 million in 2024 and is projected to reach USD 1.42 billion by 2031, exhibiting a CAGR of 6.1% during the forecast period. This growth trajectory aligns with the expanding healthcare sector, which is valued at approximately USD 603 billion as of 2023.
Medical refrigerated units are specialized cold storage solutions designed for temperaturesensitive pharmaceuticals, including vaccines, blood products, biologics, and laboratory reagents. These units comply with stringent regulatory standards like CFDA's Cold Chain Management Guide, often incorporating IoT-enabled temperature monitoring via cloudbased platforms for real-time data tracking.
USD 952 million in 2024
2032 USD 1.42 billion by 2031
of 6.1%
48L Segment Dominates the Market Due to its Compact Design and Suitability for High-Volume Hospital Storage The market is segmented based on type into:
48L 62L Other
By Application
Hospital Segment Leads Due to Extensive Use in Vaccine and Blood
Product Preservation
The market is segmented based on application into: Hospital
Our Key Players
Haier
Thermo Fisher
Meiling
Aucma
PHCBI
Alphavita
https://www.24lifesciences.com
